Premature senescence impairs hematopoietic stem cell function during sickle cell disease in mice and humans
- 22 July 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (859) , eadv0628
Abstract
Sickle cell disease (SCD) is a blood disorder affecting millions worldwide. Emerging evidence reveals that SCD pathophysiology increases the risk of myeloid malignancies and hematopoietic stem cell (HSC) dysfunction, likely because of chronic stress on bone marrow. To investigate this further, we interrogated bone marrow hematopoietic stem and progenitor cells (HSPCs) from mice and individuals with SCD and observed molecular signatures of chronic cellular stress including oxidative stress, DNA damage, and hallmarks of senescence. Consistent with these findings, SCD HSPCs displayed transcriptomic dysregulation of senescence-associated molecular programs and diminished mitogen response with prolonged cell cycle kinetics during time-lapse live cell imaging. SCD mice displayed a marked loss of immunophenotypic bone marrow HSPCs by flow cytometry and functional blood repopulating HSPCs in transplantation studies, whereas human SCD bone marrow HSPCs exhibited poor ex vivo hematopoietic colony-forming ability, and these phenotypes were reversed after senescence-targeting therapy with either ABT-263 (navitoclax) or the combination of dasatinib and quercetin. Thus, treatment with senescence-targeting therapy improves bone marrow HSPC function in vivo in mice and ex vivo in cells from individuals with SCD and could represent a possible strategy to improve HSPC health, promote manufacture of high-quality bespoke clinical products, and potentially enhance the safety of potentially curative gene therapies using autologous HSPCs from individuals with SCD.Keywords
Funding Information
- National Institutes of Health (F32HL164095)
- National Institutes of Health (R01HL174644)
- National Institutes of Health (F31HL170678)
- National Institutes of Health (U01HL163983)
- National Institutes of Health (R01HL168893)
- National Institutes of Health (T32CA236748)
- American Cancer Society (RSG-22-023-01-CDP)
- Alex's Lemonade Stand Foundation for Childhood Cancer (22-27080)
- Leukemia and Lymphoma Society
- Edward P. Evans Foundation
- American Lebanese Syrian Associated Charities
- American Lebanese Syrian Associated Charities
- American Lebanese Syrian Associated Charities
- American Lebanese Syrian Associated Charities
- American Lebanese Syrian Associated Charities
- American Lebanese Syrian Associated Charities
This publication has 70 references indexed in Scilit:
- The Evolving Landscape of Drug Therapies for Sickle Cell DiseaseHematology/Oncology Clinics of North America, 2022
- Mechanisms involved in hematopoietic stem cell agingCellular and Molecular Life Sciences, 2022
- Sickle Cell DiseaseJAMA, 2022
- 3022 – CELL SIZE IS A DETERMINANT OF STEM CELL POTENTIAL DURING AGINGExperimental Hematology, 2021
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney diseaseEBioMedicine, 2019
- Cell cycle arrest in replicative senescence is not an immediate consequence of telomere dysfunctionMechanisms of Ageing and Development, 2019
- Perturbation of Ribosome Biogenesis Drives Cells into Senescence through 5S RNP-Mediated p53 ActivationCell Reports, 2015
- A Comparison of Senescence in Mouse and Human Cells2009
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assaysJournal of Immunological Methods, 2009
- Genealogies of clones of diploid fibroblasts: Cinemicrophotographic observations of cell division patterns in relation to population ageExperimental Cell Research, 1974